MetLife マネジメント
マネジメント 基準チェック /34
MetLifeの CEO はMichel Khalafで、 May2019年に任命され、 の在任期間は 7.17年です。 の年間総報酬は$ 22.36Mで、 6.7%給与と93.3%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.09%を直接所有しており、その価値は$ 52.32M 。経営陣と取締役会の平均在任期間はそれぞれ6.7年と4.9年です。
主要情報
Michel Khalaf
最高経営責任者
US$22.4m
報酬総額
| CEO給与比率 | 6.71% |
| CEO在任期間 | 7.2yrs |
| CEOの所有権 | 0.09% |
| 経営陣の平均在職期間 | 6.7yrs |
| 取締役会の平均在任期間 | 4.9yrs |
経営陣の近況
Recent updates
分析記事 • Jun 17
MetLife (MET) Stock Could Be 47% Below Fair Value After New Settlement Product
MetLife’s new deferred payment solution puts product design in focus MetLife (MET) recently introduced the Non-Qualified Assignment Flex Agreement, or NQA-FA, a deferred payment solution that gives attorneys and brokers more control over the timing and structure of non-physical injury settlements. The NQA-FA uses a funding agreement rather than an annuity and supports features such as deferred start dates, lump sums and customized payment schedules, potentially broadening how MetLife stock...
ナラティブの更新 • Jun 09
MET: Capital Returns And Product Flexibility Will Shape Future Risk Reward Balance
Analysts have raised their price target on MetLife to $92.80 from $89.31, citing updated assumptions around fair value, discount rate, revenue growth, profit margin, and future P/E estimates. What's in the News MetLife reported Q1 2026 adjusted earnings growth of 18% year over year, with broad top line growth across all operating segments and resilient margins, supported by expanding businesses in Asia, Latin America, Group Benefits, and Retirement and Income Solutions.Seeking Alpha • Jun 08
MetLife: Not Exciting, But It Works
Summary MetLife delivers strong Q1 2026 results with adjusted EPS up 23% to $2.42 and ROE at 17%, highlighting robust core performance. I find MET's fixed-income preferreds, especially Series F, compelling with yields near 6.5% and payout ratios under 4%, offering rare quality and safety. Common shares trade at a fair 8.5x forward P/E with limited near-term upside; total equity returns approximate 8% annually via buybacks and dividends. Key risks include commercial mortgage exposure and volatile alternative investment income, but preferred dividend coverage remains exceptionally strong. Read the full article on Seeking Alphaナラティブの更新 • May 03
MET: Share Repurchases And Dividend Increases Will Support Future Upside Potential
Analysts have slightly adjusted their fair value estimate for MetLife, nudging the implied price target from about $89.06 to $89.31. This reflects modest tweaks to assumptions around the discount rate, long term revenue growth, profit margin and future P/E multiples.ナラティブの更新 • Apr 17
MET: Share Repurchases Following Index Exit Will Support Future Upside Potential
Analysts have slightly reduced their MetLife fair value estimate to $89.06 from $90.50, reflecting minor adjustments to assumptions for the discount rate, revenue growth, profit margin, and future P/E ratio that refine their outlook for the shares. What's in the News MetLife has been dropped from the S&P 100 index, which may influence how some index funds and benchmarks gain exposure to the stock (Key Developments).ナラティブの更新 • Apr 01
MET: Share Repurchases And Index Exit Will Shape Future Upside Potential
Analysts have trimmed their average MetLife price target slightly to $90.50 from $90.73, citing updated views on revenue growth, profit margins, and future P/E assumptions. What's in the News MetLife, Inc.ナラティブの更新 • Mar 18
MET: Share Repurchases Will Support Future Upside Potential
Analysts have slightly adjusted their price target for MetLife to $90.73 from $90.93, reflecting updated views on discount rates, revenue growth, profit margins, and future price-to-earnings (P/E) assumptions. What's in the News MetLife reported that from October 1, 2025 to January 31, 2026 it repurchased 7,608,263 shares, representing 1.15% of shares, for a total of US$600 million under its current buyback program (Key Developments).ナラティブの更新 • Mar 04
MET: Buybacks And Retirement Income Agreements Will Drive Future Upside
Analysts have trimmed their price target on MetLife to about $90.93 from roughly $92.93. This reflects updated views on slightly lower expected revenue growth, a modestly softer profit margin, a higher discount rate, and a largely unchanged future P/E assumption.ナラティブの更新 • Dec 16
MET: Retirement Income Agreements Will Drive Future Upside In Earnings Power
Analysts have marginally reduced their price target on MetLife to approximately 92.93 dollars from 93 dollars, citing a slightly higher assumed discount rate. This more than offsets modest improvements in forecast profit margins and valuation multiples.ナラティブの更新 • Nov 07
MET: Revenue Will Advance On New Retirement Income And Employee Support Agreements
Analysts have slightly reduced their price target for MetLife from $93.33 to $93.00, reflecting minor adjustments to discount rate and profit margin assumptions. They maintain a positive outlook on revenue growth.ナラティブの更新 • Oct 24
Digital Expansion And Employee Support Benefits Will Drive Outperformance Ahead
Analysts have modestly raised their price target for MetLife, increasing it from $93.00 to $93.33 per share. They cited slight improvements in projected revenue growth and profit margins as the reason for the adjustment.ナラティブの更新 • Oct 09
International Demand And Digital Transformation Will Fuel Success
Analysts have raised their fair value estimate for MetLife from $91.86 to $93.00. This reflects slight adjustments to discount rates and growth assumptions.ナラティブの更新 • Sep 04
International Demand And Digital Transformation Will Fuel Success
With no change in revenue growth forecasts or discount rate, MetLife’s fair value estimate remains steady at $91.86. What's in the News MetLife will redeem all outstanding shares of its 3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G, at $1,000 per share; dividends of $19.250 per share will be paid separately, and all further dividends cease post-redemption.Seeking Alpha • Feb 11
MetLife: Double-Digit EPS Growth With A Single-Digit P/E, Strong Chart
Summary MetLife, Inc. is rated a buy due to its solid value, above-market dividend yield, and favorable technical chart despite recent earnings misses. Insurance stocks, including MET, have lagged behind the Financials sector and S&P 500, with premium increases expected to slow as consumers react to rising costs. MET's 2025 outlook is positive, with analysts forecasting over 17% EPS growth and 5%-6% revenue growth, despite recent underperformance in certain segments. Key risks include lower stock prices, falling interest rates, and regulatory challenges, but MET's strong investment income and share buybacks are positive factors. Read the full article on Seeking AlphaSeeking Alpha • Nov 26
MetLife Upgraded To Buy As Financials And Insurance Show Further Upside Potential
Summary MetLife stock gets upgraded to a buy, from my prior hold rating, as indicators point to further share price potential in the financials sector, as well as the insurance subsector. Data points to future continued demand for annuities and life insurance, and MetLife has in Q3 achieved new organic customer growth in 2 key businesses. Although its dividend yield is not stellar vs. peers, it has a 10-year track record of proven dividend growth, something it has potential to continue. Even though it is trading at a 10-year high, it remains undervalued on P/E and EV/EBITDA vs. peers, so continues to present a buy opportunity. Read the full article on Seeking AlphaSeeking Alpha • Sep 23
MetLife: One Of The Best Life Insurance Stocks
Summary MetLife's strong financial performance, with a 17.5% increase in adjusted EPS and a 15.2% rise in book value, makes it an attractive investment. Despite comparable performance to Aflac, MetLife's lower valuation offers better value for shareholders. MetLife's growing dividend yield and robust share buyback program enhance shareholder value, with ample cash reserves supporting future buybacks. Risks include potential commercial real estate portfolio defaults and market volatility, but MetLife's strong fundamentals and attractive valuation make it a compelling choice. Read the full article on Seeking AlphaSeeking Alpha • Jul 09
Higher For Longer? Consider MetLife's Preferred Shares With A 6.6% Yield
Summary MetLife's preferred shares, particularly the Series A with floating dividends, offer potential for investors in a 'higher for longer' inflation and interest rate environment. MetLife's strong financial performance in Q1 2021, with net profit covering preferred dividends by less than 8%. Series A preferred shares have a minimum 4% floor for dividends, with potential for higher yields based on 3 month SOFR rate adjustments. Read the full article on Seeking AlphaSeeking Alpha • Jun 26
MetLife Looks Like An Undervalued Property In An Unpopular Neighborhood
Summary MetLife shares have outperformed peers, but life insurance stocks have not really been in favor given concerns about CRE losses and rate cuts. Higher rates have allowed MetLife to reprice its investment portfolio at higher rates and sell more spread products, and the benefits will last even as rates fall. There are understandable concerns about MetLife's CRE exposure (office in particular), as the insurer is overweight here, but losses will take years to materialize and can be absorbed. MetLife's focus on profitable core businesses like group life and health, pension risk transfer, and international markets should lead to steady growth and returns for investors. This is something of a contrarian call given weak sector sentiment, but MetLife's differentiated model and ability to out-earn its cost of equity should drive outperformance. Read the full article on Seeking AlphaCEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Mar 31 2026 | n/a | n/a | US$3b |
| Dec 31 2025 | US$22m | US$2m | US$3b |
| Sep 30 2025 | n/a | n/a | US$4b |
| Jun 30 2025 | n/a | n/a | US$4b |
| Mar 31 2025 | n/a | n/a | US$4b |
| Dec 31 2024 | US$20m | US$2m | US$4b |
| Sep 30 2024 | n/a | n/a | US$4b |
| Jun 30 2024 | n/a | n/a | US$3b |
| Mar 31 2024 | n/a | n/a | US$2b |
| Dec 31 2023 | US$21m | US$1m | US$1b |
| Sep 30 2023 | n/a | n/a | US$2b |
| Jun 30 2023 | n/a | n/a | US$3b |
| Mar 31 2023 | n/a | n/a | US$4b |
| Dec 31 2022 | US$18m | US$1m | US$5b |
| Sep 30 2022 | n/a | n/a | US$5b |
| Jun 30 2022 | n/a | n/a | US$5b |
| Mar 31 2022 | n/a | n/a | US$8b |
| Dec 31 2021 | US$17m | US$1m | US$7b |
| Sep 30 2021 | n/a | n/a | US$5b |
| Jun 30 2021 | n/a | n/a | US$4b |
| Mar 31 2021 | n/a | n/a | US$1b |
| Dec 31 2020 | US$15m | US$1m | US$5b |
| Sep 30 2020 | n/a | n/a | US$6b |
| Jun 30 2020 | n/a | n/a | US$7b |
| Mar 31 2020 | n/a | n/a | US$9b |
| Dec 31 2019 | US$15m | US$1m | US$6b |
報酬と市場: Michelの 総報酬 ($USD 22.36M ) は、 US市場 ($USD 14.46M ) の同規模の企業の平均を上回っています。
報酬と収益: Michelの報酬は、過去 1 年間の会社の業績と一致しています。
CEO
Michel Khalaf
7.2yrs
在職期間
US$22,364,273
報酬
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO, President & Director | 7.2yrs | US$22.36m | 0.090% $ 52.3m | |
| Executive VP | 8.2yrs | US$9.42m | 0.035% $ 20.1m | |
| Executive VP and Head of Global Technology & Operations | 6.7yrs | US$7.92m | 0.011% $ 6.3m | |
| Executive VP | 15.1yrs | US$6.59m | 0.019% $ 10.9m | |
| Regional President of U.S. Business & Head of MetLife Holdings | 8.8yrs | US$7.92m | 0.028% $ 16.2m | |
| Executive VP & Chief Accounting Officer | less than a year | データなし | データなし | |
| Senior VP | no data | データなし | データなし | |
| Executive VP & Chief Legal Officer | 1.5yrs | データなし | 0.0027% $ 1.6m | |
| Chief Communications Officer | 1.1yrs | データなし | データなし | |
| Executive VP & Chief Marketing Officer | 4.7yrs | データなし | データなし | |
| Executive VP & Chief Human Resources Officer | 1.9yrs | データなし | 0.0011% $ 640.3k | |
| President of MetLife Auto & Home and Senior Vice President of Eastern Zone - Individual Business | 19.5yrs | データなし | データなし |
6.7yrs
平均在職期間
53yo
平均年齢
経験豊富な経営陣: METの経営陣は経験豊富で経験豊富です（平均在職期間は6.7年）。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO, President & Director | 7.2yrs | US$22.36m | 0.090% $ 52.3m | |
| Executive VP | 5.5yrs | データなし | データなし | |
| Independent Director | 12.8yrs | US$371.79k | 0% $ 0 | |
| Independent Director | 1.2yrs | US$213.32k | データなし | |
| Independent Director | less than a year | データなし | 0.00020% $ 116.4k | |
| Independent Director | less than a year | データなし | 0.00025% $ 145.5k | |
| Independent Director | 4.3yrs | US$351.79k | 0.0017% $ 1.0m | |
| Independent Chairman | 19.4yrs | US$606.39k | 0.0012% $ 715.9k | |
| Independent Director | 7.7yrs | US$331.79k | 0.0038% $ 2.2m | |
| Independent Director | 6.9yrs | US$356.79k | 0.0030% $ 1.8m | |
| Independent Director | 3.3yrs | US$326.79k | 0% $ 0 | |
| Independent Director | 2.4yrs | US$366.79k | 0.00089% $ 518.0k |
4.9yrs
平均在職期間
63.5yo
平均年齢
経験豊富なボード: METの 取締役会 は 経験豊富 であると考えられます ( 4.9年の平均在任期間)。
企業分析と財務データの現状
| データ | 最終更新日（UTC時間） |
|---|---|
| 企業分析 | 2026/07/07 22:01 |
| 終値 | 2026/07/07 00:00 |
| 収益 | 2026/03/31 |
| 年間収益 | 2025/12/31 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
このレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。
シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
MetLife, Inc. 9 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。31
| アナリスト | 機関 |
|---|---|
| Jacob Kilstein | Argus Research Company |
| Jay Gelb | Barclays |
| Taylor Scott | Barclays |